VMI
KNSA icon

VHCP Management III’s Kiniksa Pharmaceuticals KNSA Stock Holding History

VHCP Management III’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-277,137
Closed -$2.36M – 20
2019
Q3 		$2.36M Sell
277,137
-35,183
-11% -$389K 1.46% 12
2019
Q2 		$4.23M Sell
312,320
-15,457
-5% -$240K 1.97% 12
2019
Q1 		$5.92M Hold
327,777
– – 3.45% 10
2018
Q4 		$9.21M Hold
327,777
– – 6.69% 7
2018
Q3 		$8.36M Buy
+327,777
New +$6.37M 6.32% 6

Other funds holding KNSA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VHCP Management III's KNSA Position: Q4 2019 in Review

VHCP Management III sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2019, closing a stake of 277,137 shares — an estimated $2.36M sold.

VHCP Management III first reported a position in KNSA in Q3 2018 and held it in 5 quarters. The position peaked at $9.21M in Q4 2018. 62 funds tracked by Wall St. Rank hold KNSA as of Q4 2019.

  • VHCP Management III reported no remaining Kiniksa Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • VHCP Management III sold 277,137 Kiniksa Pharmaceuticals shares in Q4 2019, an estimated $2.36M.
  • VHCP Management III first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • VHCP Management III's Kiniksa Pharmaceuticals position peaked at $9.21M in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.